Safety and Efficacy of CD207 Targeted CAR-T Cell Therapy in Patients With R/R Langerhans Cell Histiocytosis

Condition:   Langerhans Cell Histiocytosis Intervention:   Biological: CD207 CAR-T cells Sponsors:   Beijing Friendship Hospital;   Beijing Boren Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials